The pharmaceutical company, which raised $505 million through the sale of shares last year, has already leased 327,400 square feet of space in the under-construction tower.
The biotech company uses CRISPR technology licensed from UT Southwestern Medical Center in Dallas, and was co-founded by UTSW researcher and faculty member Eric Olson.
The facility, which will have an innovation lab, educational facilities, and two championship golf courses among its amenities, will elevate the game to new heights, CEO Seth Waugh says.